Myomo (MYO) Common Equity (2016 - 2025)

Myomo has reported Common Equity for 10 years, with the latest figure at $11.4 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 53.86% year-over-year to $11.4 million; the trailing twelve-month figure through Dec 2025 stood at $11.4 million (down 53.86% YoY), and the FY2025 full-year result was $11.4 million, down 53.86% from the prior year.
• Common Equity for Q4 2025 stood at $11.4 million, down from $14.6 million in the prior quarter.
• The five-year high for Common Equity was $24.7 million in Q4 2024, with the low at $6.4 million in Q4 2022.
• Historically, Common Equity has averaged $12.7 million across 5 years, with a median of $11.2 million in 2023.
• Annual changes were most pronounced in 2022 — Common Equity sank 58.73% — and 2024, when it jumped 174.93%.
• Myomo's Common Equity stood at $15.4 million in 2021, then tumbled by 58.73% to $6.4 million in 2022, then soared by 41.36% to $9.0 million in 2023, then soared by 174.93% to $24.7 million in 2024, then tumbled by 53.86% to $11.4 million in 2025.
• The last three Common Equity figures came in at $11.4 million (Q4 2025), $14.6 million (Q3 2025), and $17.6 million (Q2 2025), per Business Quant data.